Biocon's biologics facilities in Bengaluru receive GMP compliance certificate from EMA - (The Economic Times via NewsPoints Desk)

  • Biocon announced that its biologics facilities in Bengaluru have been granted good manufacturing practices (GMP) compliance by the European Medicines Agency, as reported The Economic Times Friday.

  • A company spokesperson said that the EMA inspection was conducted in March.

  • "This was a surveillance inspection of our existing drug product and drug substance facilities and a pre-approval inspection of our additional drug product manufacturing line," the drugmaker remarked.

  • Shares in Biocon fell 3.3 percent despite the news.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.